Indeed, in tumor antigen–reactive TILs in mice, CD8+cis-targeted IL2 showed a marked ability to markedly diminish Tox expression (Fig. 5I) and reduce features of exhaustion (Fig. 6J), findings that were also seen in the accompanying manuscript in human TILs (Kaptein and colleagues). The gene discussed is IL2; the disease is neoplasm.